Biomarker 101: Antinuclear antibody (ANA)

ANA is one of the most misread tests in medicine. A positive result is far more common than autoimmune disease, and that gap causes a great deal of unnecessary worry.

What the ANA test is

Antinuclear antibodies are antibodies directed at components inside the nucleus of your own cells. The test detects whether they are present and, if so, at what concentration.

Their presence can be associated with autoimmune conditions, particularly connective tissue diseases. But they also occur in people with nothing wrong at all.

Why the result is so often misleading

Here is the number that matters: roughly three in ten healthy people test positive at low levels. That proportion is higher again in older women.

The test is sensitive but not specific. It rarely misses autoimmune disease when it is present, and it also flags a large number of people who do not have it. A positive result in someone without relevant symptoms usually means very little.

This is why the test is most informative in people who already have specific reasons to suspect an autoimmune condition — and least informative when used as general screening. Ordered without a clinical reason, a positive ANA is more likely to generate anxiety and further tests than useful information.

How results are reported

Results come as a titre — how far the sample can be diluted before antibodies stop being detectable — alongside a staining pattern.

Higher titres are more likely to be meaningful. A weakly positive result is common in healthy people; a strongly positive one is less so. The staining pattern offers additional clues about which conditions might be relevant, and helps direct any further testing.

When ANA testing is appropriate

It is most useful where there are specific features suggesting autoimmune disease, rather than general or non-specific symptoms. Fatigue alone, for instance, is far more often explained by sleep, stress or something else entirely.

Features that raise the value of the test include photosensitive rashes, joint pain and swelling, colour changes in fingers with cold, persistent dry mouth and eyes, recurrent mouth ulcers, and certain blood count abnormalities. Family history of autoimmune disease also matters.

What ANA won't tell you

• A positive result is not a diagnosis. It is common in healthy people and means nothing on its own.
• It doesn't identify which condition. That requires more specific antibody testing and clinical assessment.
• It doesn't track disease activity. Once a diagnosis exists, other tests are used for monitoring; ANA is not repeated to follow progress.
• Medications and infections can cause positives. Several drug classes and some chronic infections produce them.

The bottom line

ANA is a useful test in the right situation and a poor one in the wrong situation. Its value depends almost entirely on why it was ordered — which is why it belongs in a conversation with a doctor who knows your symptoms rather than in a general screening panel.